16+
Major trials tracked
Immuno-oncology checkpoint inhibitors · Live ClinicalTrials.gov data
Nivolumab (Opdivo) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 nivolumab (Opdivo) trials on ClinicalTrials.gov by enrolment, 5 of them actively recruiting. The next phase 3 primary completion among them is expected Nov 2028. Refreshed daily. Add up to four competitors to compare pipelines side by side.
2
Phase 3 trials
5
Actively recruiting
Nov 2028
Next phase 3 primary completion
14,093
Participants across trials
Bristol-Myers Squibb
Lead sponsor by trial count
nivolumab (16)12 active2013–2033
nivolumab
'13
'15
'17
'19
'21
'23
'25
'27
'29
'31
'33
nivolumab
Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma (CheckMate 064)P2
Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung CancerP2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)P2
TAPURP2
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced CancersP4
CheckMate 908P2
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin LymphomaP3
CaboPointP2
TONIC-2P2
Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal CarcinomaP2
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaP3
ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)P2
Nivo40-AVD for Advanced Classic Hodgkin LymphomaP2
Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II TrialP2
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal CancerP2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialP2
Upcoming readouts
7 ahead · nivolumab
Select a trial to load its full ClinicalTrials.gov record.
Key nivolumab trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track nivolumab with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for nivolumab?
- ClinicalTrials.gov lists more than 16 phase 2–4 nivolumab trials. This page tracks the 16 largest by enrolment: 13 phase 2, 2 phase 3, and 1 phase 4 among them, with 5 actively recruiting. Updated daily.
- Are there clinical trials for Opdivo?
- Opdivo is the brand name for nivolumab, so nivolumab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 nivolumab trials. This page tracks the 16 largest by enrolment: 13 phase 2, 2 phase 3, and 1 phase 4 among them, with 5 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare nivolumab against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
